MedPath

Tizanidine

These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996

Approved
Approval ID

b68a9f81-7138-48cf-b987-b8d284e8105a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 15, 2023

Manufacturers
FDA

Quality Care Products, LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tizanidine

PRODUCT DETAILS

NDC Product Code35356-662
Application NumberANDA076286
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJune 15, 2021
Generic NameTizanidine

INGREDIENTS (5)

Tizanidine HydrochlorideActive
Quantity: 2 mg in 1 1
Code: B53E3NMY5C
Classification: ACTIM
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
stearic acidInactive
Code: 4ELV7Z65AP
Classification: IACT
anhydrous lactoseInactive
Code: 3SY5LH9PMK
Classification: IACT
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tizanidine - FDA Drug Approval Details